EANS-News: Symrise AG´s annual general meeting elects two new supervisory board members
-------------------------------------------------------------------------------- Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. --------------------------------------------------------------------------------
Annual & Special Corporate Meetings
Holzminden (euro adhoc) - Prof. Dr. Andrea Pfeifer and Dr. Michael Becker newly elected to supervisory board Dr. Thomas Rabe is new chairman of the supervisory board Higher dividend of EUR 0.60 (+ 20%) approved
At the 2011 annual general meeting of Symrise AG, which was held in Hannover today, all proposals were approved by a large majority of the shareholders in attendance. The agenda included a vote on increasing the dividend by 20 % over the previous year to EUR 0.60 per share and the election of two new shareholder representatives to the supervisory board. The shareholders in attendance represented 72% of the equity.
In his speech to the approximate 300 shareholders, Chief Executive Officer Dr. Heinz-Jürgen Bertram looked back at the extraordinarily successful fiscal year 2010. Symrise benefited from the global economic recovery and a strong boost in demand, as well as the excellent positioning in emerging markets and the business with large customers. The Group has had a good start in the current financial year. The results for the first quarter confirm that the Group is well positioned to achieving its objectives for 2011.
An important item on the agenda was the election of the shareholder representatives to the supervisory board, as the term of all members expired at this year´s general meeting. Andreas Schmid, supervisory board chairman to date, as well as shareholder representative Sanna Suvanto-Harsaae had indicated prior to the meeting that they would not stand for reelection due to personal or professional reasons. The management and supervisory board thanked Mr. Schmid and Mrs. Suvanto-Harsaae for their dedicated work in past years.
Dr. Michael Becker, a personally liable partner and member of the management board of Merck KGaA, Darmstadt, and Prof. Dr. Andrea Pfeifer, chief executive officer of AC Immune S.A., Légier, Switzerland, were newly elected to the supervisory board. The previous shareholder representatives Horst-Otto Gerberding, Dr. Peter Grafoner, Dr. Hans-Heinrich Gürtler and Dr. Thomas Rabe were reconfirmed to their posts on the supervisory board. Dr. Rabe was elected supervisory board chairman at a constituent session of the supervisory board following the annual general meeting.
In selecting the new shareholder representatives the nomination committee placed special emphasis on comprehensive expertise in fields relevant to the company, a strong scientific background and extensive management experience.
Dr. Heinz-Jürgen Bertram said: "We are very glad to be able to welcome to our supervisory board two top-class and experienced managers, namely Professor Pfeifer and Dr. Becker. Both bring with them extensive sector expertise and management experience that will be very valuable to Symrise."
Dr. Michael Becker has been a member of the management board of Merck KGaA for over ten years. Among other things he heads the departments of accounting, controlling, finance, mergers & acquisitions, investor relations and purchasing.
Prof. Dr. Andrea Pfeifer is the founder and chief executive officer of AC Immune SA in Switzerland, a professor at the University of Lausanne, administrative board president of BioMedinvestor AG, Basel, Switzerland, and has extensive experience in the field of molecular and cell research. As a member of the supervisory board Prof. Dr. Pfeifer will, among other things, support Symrise in increasing its strategic focus on the field of consumer health.
About Symrise
Symrise is a global supplier of fragrances, flavorings and raw materials as well as active ingredients for the perfume, cosmetics and food industry.
Its sales of EUR 1.572 billion in 2010 place the Company among the top four in the international flavor and fragrance market. Headquartered in Holzminden, Germany, Symrise is represented in more than 35 countries in Europe, Asia, the United States and South America.
Used by manufacturers of perfumes, cosmetics and foods, our innovative products are an inseparable part of daily life. At Symrise we combine an awareness of consumer trends with cutting-edge technologies, focusing on developing innovative fashion and lifestyle products that have additional practical value for the consumer. Symrise - always inspiring more
end of announcement euro adhoc --------------------------------------------------------------------------------
company: Symrise AG
Mühlenfeldstraße 1
D-37603 Holzminden
phone: +49 (0) 5531/90-0
FAX: +49 (0) 5531/90-1649
mail: ir@symrise.com
WWW: http://www.symrise.com
sector: Chemicals
ISIN: DE000SYM9999
indexes: MDAX
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
Hamburg, Stuttgart, Düsseldorf, Hannover, München
language: EnglishFurther inquiry note:
Symrise AG
Bernhard Kott
Phone +49 (0)5531 90-1721
Email: bernhard.kott@symrise.com
Branche: Chemicals
ISIN: DE000SYM9999
WKN: SYM999
Index: MDAX
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade
Original-Content von: Symrise AG, übermittelt durch news aktuell